Sichuan Goldstone Asia Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: CNE100001YX5
CNY
9.99
1.03 (11.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sichuan Goldstone Asia Pharmaceutical, Inc.

Why is Sichuan Goldstone Asia Pharmaceutical, Inc. ?

1
With a growth in Net Profit of 232.83%, the company declared Very Positive results in Mar 26
  • The company has declared positive results for the last 3 consecutive quarters
  • ROCE(HY) Highest at 7.14%
  • INTEREST COVERAGE RATIO(Q) Highest at 51,050.15
  • RAW MATERIAL COST(Y) Fallen by -17.06% (YoY)
2
With ROE of 6.61%, it has a very attractive valuation with a 0.68 Price to Book Value
  • Over the past year, while the stock has generated a return of -1.32%, its profits have risen by 207.7% ; the PEG ratio of the company is 0.1
  • At the current price, the company has a high dividend yield of 0.8
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Sichuan Goldstone Asia Pharmaceutical, Inc. should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sichuan Goldstone Asia Pharmaceutical, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sichuan Goldstone Asia Pharmaceutical, Inc.
7.65%
0.39
38.54%
China Shanghai Composite
21.43%
1.73
13.79%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.65%
EBIT Growth (5y)
25.43%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.42
Tax Ratio
21.22%
Dividend Payout Ratio
25.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.80%
ROE (avg)
5.07%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.68
EV to EBIT
7.18
EV to EBITDA
5.05
EV to Capital Employed
0.61
EV to Sales
1.24
PEG Ratio
0.05
Dividend Yield
0.76%
ROCE (Latest)
8.53%
ROE (Latest)
6.61%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
ROCE(HY)

Highest at 7.14%

INTEREST COVERAGE RATIO(Q)

Highest at 51,050.15

RAW MATERIAL COST(Y)

Fallen by -17.06% (YoY

CASH AND EQV(HY)

Highest at CNY 1,157.14 MM

NET SALES(Q)

Highest at CNY 331.49 MM

OPERATING PROFIT(Q)

Highest at CNY 124.04 MM

OPERATING PROFIT MARGIN(Q)

Highest at 37.42 %

PRE-TAX PROFIT(Q)

Highest at CNY 129.77 MM

NET PROFIT(Q)

Highest at CNY 114.73 MM

EPS(Q)

Highest at CNY 0.29

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Sichuan Goldstone Asia Pharmaceutical, Inc.

Pre-Tax Profit
At CNY 129.77 MM has Grown at 230.04%
over average net sales of the previous four periods of CNY 39.32 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 114.73 MM has Grown at 264.81%
over average net sales of the previous four periods of CNY 31.45 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Interest Coverage Ratio
Highest at 51,050.15
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at CNY 331.49 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Sales
At CNY 331.49 MM has Grown at 27.69%
over average net sales of the previous four periods of CNY 259.6 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit
Highest at CNY 124.04 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin
Highest at 37.42 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CNY 129.77 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 114.73 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.29
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 1,157.14 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -17.06% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales